Cat.#: ACPP-1153
| Despition | MERTK Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1435 | Human CHGA Protein, His (AC1435) | 2 µg | inquiry |
| ACPP-1771 | Human ATG3 Protein (AC1771) | 5 µg | inquiry |
| ACPP-1570 | Human Acrp30 Protein, Trimeric (AC1570) | 2 µg | inquiry |
| ACPP-1365 | Progesterone Receptor Blocking Peptide (AC1365) | 250 µg | inquiry |
| ACPP-1614 | Human MPPED2 Protein (AC1614) | 2 µg | inquiry |
| ACPP-1504 | Human CPLX1 Protein (AC1504) | 10 µg | inquiry |
| ACPP-1754 | Human VEGFC Protein, Sf9 (AC1754) | 2 µg | inquiry |
| ACPP-1354 | PAX2 Blocking Peptide (AC1354) | 250 µg | inquiry |
| ACPP-1823 | Human SOX2 Protein, TAT (AC1823) | 5 µg | inquiry |
| ACPP-1100 | Synthetic Membrane Nanoparticle Human Somatostatin Receptor 2 Protein (AC1100) | 50 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.